Ex parte ANHAUSER et al. - Page 5




          Appeal No. 1998-0244                                                        
          Application No. 08/531,890                                                  

          Szycher and Sablotsky to overcome the first deficiency and                  
          Morgan and Blackford to overcome the second.                                
               Szycher discloses a transdermal patch 10 composed of a                 
          substrate 12, a pressure sensitive adhesive 14, a drug                      
          releasing member 16 and optionally a second layer of adhesive               
          18, these elements being arranged as shown in Figure 3.  The                
          optional second layer of adhesive 18 allows the patch to be                 
          adhered to the targeted site (see column 4, lines 45 through                
          54).  Szycher indicates in very general terms that the patch                
          is made by successively adding its constituent layers to the                
          substrate 12 (see column 6, lines 40 through 59).                           
               Sablotsky discloses “a dermal composition suitable for                 
          use in the transdermal delivery of drugs, which composition                 
          permits a high loading of medicament as well as a low loading               
          of medicament into the formulation while maintaining                        
          acceptable shear, tack and peel adhesive properties” (column                
          2, lines 5 through 10).  As for the system in which this                    
          composition is used, Sablotsky states that                                  
                    [t]he transdermal drug delivery system of this                    
               invention has a defined geometric shape, with a                        
               release liner on one side.  Removal of the liner                       
               exposes the pressure sensitive adhesive that                           
               functions as the drug carrier and as the means of                      
               applying the system to the patient.  The pressure-                     
                                          5                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007